Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics
Document Type
Article
Publication Date
6-1-2024
Abstract
Sine oculis homeoprotein 1 (SIX1), a prominent representative of the homeodomain transcription factors within the SIX family, has attracted significant interest owing to its role in tumorigenesis, cancer progression, and prognostic assessments. Initially recognized for its pivotal role in embryonic development, SIX1 has emerged as a resurgent factor across a diverse set of mammalian cancers. Over the past two decades, numerous investigations have emphasized SIX1's dual significance as a developmental regulator and central player in oncogenic processes. A mounting body of evidence links SIX1 to the initiation of diverse cancers, encompassing enhanced cellular metabolism and advancement. This review provides an overview of the multifaceted roles of SIX1 in both normal development and oncogenic processes, emphasizing its importance as a possible therapeutic target and prognostic marker. Additionally, this review discusses the natural product agents that inhibit various pro-oncogenic mechanisms associated with SIX1.
Keywords
Sine oculis homeoprotein 1 (SIX1), Natural products, Metastasis, And metabolism
Divisions
CHEMISTRY
Funders
National Natural Science Foundation of China (NSFC) (82204227),Lanzhou University from China (561120202),Pancreatic Cancer Action Network Career Development Award in memory of Skip (22-20-HOBB),Concern Foundation Career Development Award,United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) (P20 GM130457)
Publication Title
Heliyon
Volume
10
Issue
12
Publisher
Cell Press
Publisher Location
50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA